BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1362829)

  • 1. The hairless mouse model for assaying the atrophogenicity of topical corticosteroids.
    Woodbury R; Kligman AM
    Acta Derm Venereol; 1992 Nov; 72(6):403-6. PubMed ID: 1362829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hairless mouse as a model for study of local and systemic atrophogenic effects following topical application of corticosteroids.
    van den Hoven WE; van den Berg TP; Korstanje C
    Acta Derm Venereol; 1991; 71(1):29-31. PubMed ID: 1676210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dorsal skin reactions of hairless dogs to topical treatment with corticosteroids.
    Kimura T; Doi K
    Toxicol Pathol; 1999; 27(5):528-35. PubMed ID: 10528632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of atrophogenicity of popularly prescribed topical corticosteroids.
    Dykes PJ; Marks R; Blakemore CB
    Br J Clin Pract; 1978 Dec; 32(12):345-8. PubMed ID: 737113
    [No Abstract]   [Full Text] [Related]  

  • 5. Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy.
    McMichael AJ; Griffiths CE; Talwar HS; Finkel LJ; Rafal ES; Hamilton TA; Voorhees JJ
    Br J Dermatol; 1996 Jul; 135(1):60-4. PubMed ID: 8776360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Duhring chamber assay for corticosteroid atrophy.
    Frosch PJ; Behrenbeck EM; Frosch K; Macher E
    Br J Dermatol; 1981 Jan; 104(1):57-65. PubMed ID: 7459270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for the assessment of skin atrophogenicity of topical corticosteroids.
    Marks R
    Dermatologica; 1976; 152 Suppl 1():117-26. PubMed ID: 133834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid assay of the anti-inflammatory activity of topical corticosteroids by inhibition of a UVA-induced neutrophil infiltration in hairless mouse skin. I. The assay and its sensitivity.
    Woodbury RA; Kligman LH; Woodbury MJ; Kligman AM
    Acta Derm Venereol; 1994 Jan; 74(1):15-7. PubMed ID: 7908479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel in vitro test systems for the determination of glucocorticoid receptor ligand-induced skin atrophy.
    Schoepe S; Schäcke H; Bernd A; Zöller N; Asadullah K
    Skin Pharmacol Physiol; 2010; 23(3):139-51. PubMed ID: 20051715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of topical ammonium lactate on cutaneous atrophy from a potent topical corticosteroid.
    Lavker RM; Kaidbey K; Leyden JJ
    J Am Acad Dermatol; 1992 Apr; 26(4):535-44. PubMed ID: 1597538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the atrophogenic potential of different glucocorticoids using optical coherence tomography, 20-MHz ultrasound and profilometry; a double-blind, placebo-controlled trial.
    Cossmann M; Welzel J
    Br J Dermatol; 2006 Oct; 155(4):700-6. PubMed ID: 16965418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Permeability barrier abnormality of hairless mouse epidermis after topical corticosteroid: characterization of stratum corneum lipids by ruthenium tetroxide staining and high-performance thin-layer chromatography.
    Sheu HM; Lee JY; Kuo KW; Tsai JC
    J Dermatol; 1998 May; 25(5):281-9. PubMed ID: 9640880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of glucocorticoid-induced epidermal and dermal atrophy with KH 1060--a potent 20-epi analogue of 1,25-dihydroxyvitamin D3.
    Gniadecki R; Gniadecka M; Serup J
    Br J Pharmacol; 1994 Oct; 113(2):439-44. PubMed ID: 7834193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of topical crude coal tar treatment on unstimulated hairless hamster skin.
    Foreman MI; Picton W; Lukowiecki GA; Clark C
    Br J Dermatol; 1979 Jun; 100(6):707-15. PubMed ID: 157153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sunscreens with low sun protection factor inhibit ultraviolet B and A photoaging in the skin of the hairless albino mouse.
    Harrison JA; Walker SL; Plastow SR; Batt MD; Hawk JL; Young AR
    Photodermatol Photoimmunol Photomed; 1991 Feb; 8(1):12-20. PubMed ID: 1768605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agents that cause enlargement of sebaceous glands in hairless mice. I. Topical substances.
    Lesnik RH; Kligman LH; Kligman AM
    Arch Dermatol Res; 1992; 284(2):100-5. PubMed ID: 1610208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of tea and caffeine on UV-induced carcinogenesis: relationship to enhanced apoptosis and decreased tissue fat.
    Conney AH; Lu YP; Lou YR; Huang MT
    Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S28-36. PubMed ID: 12570332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of an atopic dermatitis-like skin model in a hairless mouse by repeated elicitation of contact hypersensitivity that enables to conduct functional analyses of the stratum corneum with various non-invasive biophysical instruments.
    Matsumoto K; Mizukoshi K; Oyobikawa M; Ohshima H; Tagami H
    Skin Res Technol; 2004 May; 10(2):122-9. PubMed ID: 15059180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid assay of the anti-inflammatory activity of topical corticosteroids by inhibition of a UVA-induced neutrophil infiltration in hairless mouse skin. II. Assessment of name brand versus generic potency.
    Kligman LH
    Acta Derm Venereol; 1994 Jan; 74(1):18-9. PubMed ID: 7908480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of topical application of 13-cis retinoic acid on skin of hairless rats and hairless mice.
    Puhvel SM; Sakamoto M
    Arch Dermatol Res; 1985; 277(5):395-9. PubMed ID: 3161459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.